Stockreport

Denali Therapeutics (DNLI) Is Up 5.1% After Highlighting Tividenofusp Alfa Ahead Of FDA Decision – Has The Bull Case Changed? [Yahoo! Finance]

Denali Therapeutics Inc.  (DNLI) 
Last denali therapeutics inc. earnings: 8/6 04:30 pm Check Earnings Report
US:NASDAQ Investor Relations: investors.denalitherapeutics.com
PDF Investor attention is increasingly centered on tividenofusp alfa for Hunter syndrome, with an upcoming FDA action date viewed as a key test of Denali's therapeutic appr [Read more]